BCL2L1 and ovarian carcinoma: Since belinostat used at cytostatic concentration increased the expression of Bim and Puma while partially repressing that of Bcl‐xL, we hypothesized that combining it with strategies inhibiting residual Bcl‐xL or Mcl‐1 proteins might be effective in inducing apoptosis in ovarian cancer cells.